★ WIDE MOAT STOCKS COMPARISON ★

Checking

Stock Comparison

Stevanato Group S.p.A. vs West Pharmaceutical Services, Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Stevanato Group S.p.A.

STVN · New York Stock Exchange

Market cap (USD)$4.9B
Gross margin (TTM)29%
Operating margin (TTM)16.6%
Net margin (TTM)11.8%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryIT
Data as of2026-07-12
Moat score
69/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Stevanato Group S.p.A.'s moat claims, evidence, and risks.

View STVN analysis

West Pharmaceutical Services, Inc.

WST · New York Stock Exchange

Market cap (USD)$25.8B
Gross margin (TTM)36.2%
Operating margin (TTM)20.7%
Net margin (TTM)16.9%
SectorHealthcare
IndustryMedical - Instruments & Supplies
CountryUS
Data as of2026-07-12
Moat score
90/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into West Pharmaceutical Services, Inc.'s moat claims, evidence, and risks.

View WST analysis

Comparison highlights

  • Moat score gap: West Pharmaceutical Services, Inc. leads (90 / 100 vs 69 / 100 for Stevanato Group S.p.A.).
  • Segment focus: Stevanato Group S.p.A. has 3 segments (47% in High-Value Solutions); West Pharmaceutical Services, Inc. has 2 segments (82.2% in Proprietary Products).
  • Primary market structure: Oligopoly vs Quasi-Monopoly. Pricing power: Strong vs Moderate.
  • Moat breadth: Stevanato Group S.p.A. has 6 moat types across 3 domains; West Pharmaceutical Services, Inc. has 2 across 2.

Primary market context

Stevanato Group S.p.A.

High-Value Solutions

Market

High-value primary packaging and integrated solutions for injectable drugs

Geography

Global

Customer

Pharmaceutical, biotechnology, and life sciences companies; fill-finish CMOs

Role

Primary packaging/component manufacturer (ready-to-use), plus supporting services

Revenue share

47%

West Pharmaceutical Services, Inc.

Proprietary Products

Market

Injectable primary packaging components and containment/delivery systems (elastomeric stoppers, seals, plungers, syringe/cartridge components; related services)

Geography

Global

Customer

Biologic, generic, and pharmaceutical drug manufacturers

Role

Primary packaging and delivery component supplier

Revenue share

82.2%

Side-by-side metrics

Stevanato Group S.p.A.
West Pharmaceutical Services, Inc.
Ticker / Exchange
STVN - New York Stock Exchange
WST - New York Stock Exchange
Market cap (USD)
$4.9B
$25.8B
Gross margin (TTM)
29%
36.2%
Operating margin (TTM)
16.6%
20.7%
Net margin (TTM)
11.8%
16.9%
Sector
Healthcare
Healthcare
Industry
Medical - Instruments & Supplies
Medical - Instruments & Supplies
HQ country
IT
US
Primary segment
High-Value Solutions
Proprietary Products
Market structure
Oligopoly
Quasi-Monopoly
Market share
n/a
70%-75% (reported)
HHI estimate
n/a
n/a
Pricing power
Strong
Moderate
Moat score
69 / 100
90 / 100
Moat domains
Demand, Supply, Network
Demand, Supply
Last update
2026-07-12
2026-07-12

Moat coverage

Shared moat types

Design In QualificationCapex Knowhow Scale

Stevanato Group S.p.A. strengths

De Facto StandardBrand TrustLong Term ContractsInstalled Base Consumables

West Pharmaceutical Services, Inc. strengths

No unique moat types yet.

Segment mix

Stevanato Group S.p.A. segments

Full profile >

High-Value Solutions

Oligopoly

47%

Other Containment and Delivery Solutions

Competitive

44%

Engineering

Competitive

9%

West Pharmaceutical Services, Inc. segments

Full profile >

Proprietary Products

Quasi-Monopoly

82.2%

West Vantage

Competitive

17.8%

Act on this comparison

Turn a two-stock debate into a systemSee the systematic rankings that surface stocks like STVN and WST, with backtests and current holdings.

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Looking for expansion-stage stocks?

Proven models entering the expansion stage with unit economics that work.

View expansion-stage stocks

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.